CRP and neoplasm: A newly invented PRE-Stage was developed using a CRP–albumin–lymphocyte index < 3, central tumor location, and CA19-9 level > 40 U/mL, and it was able to significantly predict DSS and DFS when the patients were stratified into four stages (p < 0.05).